These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21131645)

  • 1. Successful clearance of hepatitis C virus with pegylated interferon α-2a and ribavirin in an etanercept-treated patient with psoriatic arthritis, hepatitis B virus coinfection and latent tuberculosis.
    Mederacke I; Witte T; Wedemeyer H; Meyer-Olson D
    Ann Rheum Dis; 2011 Jul; 70(7):1343-4. PubMed ID: 21131645
    [No Abstract]   [Full Text] [Related]  

  • 2. Etanercept as prophylactic psoriatic therapy before interferon-alpha and ribavirin treatment for active hepatitis C infection.
    Behnam SE; Hindiyeh R; Fife DJ; Jeffes EW; Wu JJ
    Clin Exp Dermatol; 2010 Jun; 35(4):397-8. PubMed ID: 19663835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic hepatitis C responds poorly to combination therapy in chronic hepatis B carriers.
    Senturk H; Tahan V; Canbakan B; Uraz S; Ulger Y; Ozaras R; Tabak F; Mert A; Ozbay G
    Neth J Med; 2008 May; 66(5):191-5. PubMed ID: 18490796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pegylated interferon alpha-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy.
    Liu CH; Liang CC; Liu CJ; Tsai HB; Hung PH; Hsu SJ; Chen SI; Lin JW; Lai MY; Chen JH; Chen PJ; Chen DS; Kao JH
    Gut; 2009 Feb; 58(2):314-6. PubMed ID: 19136527
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunoglobulin G4-associated de novo autoimmune hepatitis after liver transplantation for chronic hepatitis B- and C-related cirrhosis and hepatocellular carcinoma: a case report with literature review.
    Zhao XY; Rakhda MI; Wang TI; Jia JD
    Transplant Proc; 2013 Mar; 45(2):824-7. PubMed ID: 23498828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced efficacy of pegylated interferon alpha-2a over pegylated interferon and ribavirin in chronic hepatitis C genotype 4A randomized trial and quality of life analysis.
    Kamal SM; Ahmed A; Mahmoud S; Nabegh L; El Gohary I; Obadan I; Hafez T; Ghoraba D; Aziz AA; Metaoei M
    Liver Int; 2011 Mar; 31(3):401-11. PubMed ID: 21281434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pegylated interferon alfa-2a and ribavirin treatment for recurrent hepatitis C: role of steatosis and body mass index.
    Testino G; Gentile R; Ansaldi F; Borro P; Ravetti G; Icardi G; Sumberaz A
    Panminerva Med; 2009 Jun; 51(2):135-6. PubMed ID: 19776716
    [No Abstract]   [Full Text] [Related]  

  • 8. [Tuberculous lymphadenitis after successful treatment of hepatitis C].
    Velasco J; González S
    Enferm Infecc Microbiol Clin; 2011 Oct; 29(8):631. PubMed ID: 21570741
    [No Abstract]   [Full Text] [Related]  

  • 9. Etanercept therapy for patients with psoriatic arthritis and concurrent hepatitis C virus infection: report of 3 cases.
    Magliocco MA; Gottlieb AB
    J Am Acad Dermatol; 2004 Oct; 51(4):580-4. PubMed ID: 15389194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hepatitis C virus-associated inflammatory polyneuropathy with pegylated interferon-alpha and ribavirin.
    Trebst C; Wedemeyer H; Manns MP; Tillmann H; Windhagen A
    Eur J Gastroenterol Hepatol; 2007 Jan; 19(1):91-2. PubMed ID: 17206084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic hepatitis C virus hepatitis and psoriasis: no longer a contraindication to interferon use in the era of biological agents?
    Bartalesi F; Salomoni E; Cavallo A; Corti G; Pimpinelli N; Bartoloni A; Taliani G
    Scand J Infect Dis; 2013 Apr; 45(4):320-3. PubMed ID: 23113733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients.
    Zeuzem S
    J Hepatol; 2008 Aug; 49(2):157-9. PubMed ID: 18554745
    [No Abstract]   [Full Text] [Related]  

  • 13. Sustained HCV-RNA response and hepatitis Bs seroconversion after individualized antiviral therapy with pegylated interferon alpha plus ribavirin and active vaccination in a hepatitis C virus/hepatitis B virus-coinfected patient.
    Potthoff A; Deterding K; Trautwein C; Rifai K; Manns MP; Wedemeyer H
    Eur J Gastroenterol Hepatol; 2007 Oct; 19(10):906-9. PubMed ID: 17873617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pegylated interferon α-2a and ribavirin antiviral therapy efficacy for treating chronic hepatitis C and its effects on psychological status of patients].
    An J; Qiao J; Ni W
    Zhonghua Gan Zang Bing Za Zhi; 2014 Oct; 22(10):772-3. PubMed ID: 25558497
    [No Abstract]   [Full Text] [Related]  

  • 15. Hepatitis B virus and hepatitis C virus co-infection: a therapeutic challenge.
    Hamzaoui L; El Bouchtili S; Siai K; Mahmoudi M; Azzouz MM
    Clin Res Hepatol Gastroenterol; 2013 Feb; 37(1):e16-20. PubMed ID: 22959099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [PEG-interferons: significance for the treatment of viral hepatitis B and C].
    Wedemeyer H; Cornberg M; Manns MP
    Dtsch Med Wochenschr; 2001 Jun; 126 Suppl 1():S68-75. PubMed ID: 11450618
    [No Abstract]   [Full Text] [Related]  

  • 17. Chronic hepatitis C genotype 6 responds better to pegylated interferon and ribavirin combination therapy than genotype 1.
    Tsang OT; Zee JS; Chan JM; Li RS; Kan YM; Li FT; Lo FH; Chow DA; Cheung KW; Chan KH; Yeung YW; Ng FH; Li MK; Kwan WK; Lai TS
    J Gastroenterol Hepatol; 2010 Apr; 25(4):766-71. PubMed ID: 20492332
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Real-Life" comparison of pegylated-interferon 2a versus 2b combination therapy of chronic hepatitis C virus.
    Schulze Zur Wiesch J; Pudelski N; Hoepner L; Supplieth M; Buggisch P; Lohse AW; Lüth S
    Hepatology; 2011 Apr; 53(4):1405-6; author reply 1407. PubMed ID: 21480360
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of patients with dual hepatitis B and C: a step in the right direction.
    Aghemo A; Colombo M
    Gut; 2014 Mar; 63(3):380-1. PubMed ID: 23921890
    [No Abstract]   [Full Text] [Related]  

  • 20. [Reactivation of tuberculosis during dual therapy with pegylated interferon and ribavirin for chronic hepatitis C].
    Belkahla N; Kchir H; Maamouri N; Ouerghi H; Hariz FB; Chouaib S; Chaabouni H; Mami NB
    Rev Med Interne; 2010 Nov; 31(11):e1-3. PubMed ID: 20605283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.